Minoxidil Tablet (Minoxidil)
Minoxidil 5mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.
MFDS item code 202103531 · Notified 2021.04.30
This product's status changed to Approval withdrawn on 2024.10.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of symptomatic hypertension with target-organ damage and resistant hypertension
This medication is used for hypertension caused by symptoms or specific organ damage. It also helps in the treatment of resistant hypertension that does not respond to the combination of two or more diuretics and antihypertensives. Therefore, this drug is effectively utilized in the management of complex hypertension.
Adults (12 years and older): The initial dose is minoxidil 5㎎ orally once daily, with a maintenance dose of 10-40㎎ daily in 1 or divided doses. Up to 100㎎ may be administered daily. Frequency of administration: During treatment with this medicine, the magnitude of variation in arterial blood pressure over the course of a day is proportional to the reduction in blood pressure. If the decrease in supine diastolic blood pressure is less than 30mmHg, it may be administered once daily; if the decrease in supine diastolic blood pressure is 30mmHg or more, administer the daily dose in 2 divided doses. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow at least 3 days between adjustments, as an adequate response to a dose change may take 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while carefully monitoring the patient. Concomitant administration 1) Diuretics: This medicine is administered with a diuretic to patients whose maintenance of salt and water balance depends on renal function. It has been coadministered with the following diuretics. ① Hydrochlorothiazide (50㎎ per dose twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose once daily) ③ Furosemide (40㎎ per dose twice daily) If excessive salt and water retention results in a weight gain of approximately 1.8㎏ or more, the diuretic should be changed to furosemide. If the patient is already receiving furosemide, increase the dose as needed. 2) β-blockers or other sympatholytic agents: During treatment with this medicine, administer a β-blocker in divided doses equivalent to propranolol 80-160㎎ daily. If β-blockers are contraindicated, methyldopa (250-750㎎ per dose twice daily) may be given instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medicine. Sympatholytic agents may not completely prevent the increase in heart rate caused by this medicine, but can generally prevent tachycardia. Patients receiving a β-blocker before starting treatment with this medicine typically have bradycardia; however, their heart rate is expected to increase to normal after starting this medicine. When this medicine is administered concomitantly with a β-blocker or other sympatholytic agent, their opposing effects on the heart largely offset each other, resulting in little change in heart rate. Adjust the dose appropriately according to age and symptoms.
Children (12 years and under): The initial dose is 0.2㎎ per ㎏ of body weight once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎ per ㎏ of body weight daily. Up to 50㎎ may be administered daily.
This medication should not be used in patients with specific diseases. For example, patients with a rare tumor called pheochromocytoma, those with pulmonary hypertension due to mitral stenosis, acute myocardial infarction patients, and those with hypersensitivity to the drug should not be treated with it. Use with caution in patients with chronic congestive heart failure, severe renal failure, and angina pectoris, as these patients should be administered under strict medical supervision. This medication may cause abnormal excessive hair growth (hypertrichosis), which primarily starts around the face and scalp and may spread throughout the body. This phenomenon gradually disappears after discontinuation of the drug but may take several months for complete recovery. Children and women, in particular, should be adequately informed about these side effects. Skin rashes or allergic reactions may occur, and blood tests may reveal reduced platelet or white blood cell counts. Electrocardiograms may show changes in the heart's electrical signals, but this rarely results in significant clinical issues. Rarely, pericardial effusion, which is the accumulation of fluid around the heart, may occur and is more frequent in patients with reduced kidney function and should be observed carefully. This drug is often used in combination with diuretics to prevent the accumulation of body fluids and salts; as heart rate may increase, it can be combined with heart medications as needed. In patients with impaired kidney function, dosage adjustment is necessary, and it is safe to administer only when stabilized after myocardial infarction. In the initial stages of treatment, regular monitoring through urinalysis, renal function tests, ECG, chest X-rays, and echocardiograms is required. This drug can interact with other medications; therefore, caution is needed when used concurrently with guanethidine, antidepressants, antipsychotics, corticosteroids, and non-steroidal anti-inflammatory drugs. During pregnancy, safety has not been established, so it should be avoided, and while breastfeeding, either administration should be avoided or breastfeeding should be discontinued. There is limited experience using this medication in children or newborns, and it should be administered with extra caution. If this drug is overdosed, immediate consultation with healthcare professionals is necessary, and interventions to maintain blood pressure and facilitate urine excretion may be required. Some sympathomimetics should be avoided as they can stress the heart if overdosed.
Hirsutism, thickening, increased pigmentation, exudative rash, vesicular lesions, skin and mucous membrane syndrome, thrombocytopenia, leukopenia, decreased hematocrit, decreased hemoglobin, decreased red blood cells, increased ALP, changes in direction and amplitude of ECG T waves, pericardial effusion, ischemia, peripheral vascular edema, increased heart rate, elevated creatinine, elevated BUN, gastrointestinal disturbances, rash, mastalgia, gynecomastia, hemolytic anemia, pulmonary infiltration, increased antinuclear antibodies, headache, intermittent claudication, frequent menstruation, nausea, vomiting
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1°C and 30°C.
White round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Minoxidil 5mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

Minoxidil 5mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 3g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hanmi Pharmaceutical Co., Ltd.
Minoxidil 5g
Solution · OTC medication
JW Pharmaceutical Corp.
Minoxidil 3g
Solution · OTC medication
Haitai HTB Co., Ltd.
Minoxidil 5g
Solution · OTC medication
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.